No Cover Image

Journal article 479 views 192 downloads

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial / Steve, Bain

The Lancet Diabetes & Endocrinology, Volume: 5, Issue: 4, Pages: 251 - 260

Swansea University Author: Steve, Bain

Published in: The Lancet Diabetes & Endocrinology
ISSN: 22138587
Published: 2017
Online Access: Check full text

Tags: Add Tag
No Tags, Be the first to tag this record!
College: Swansea University Medical School
Issue: 4
Start Page: 251
End Page: 260